临床误诊误治2017，Vol.30Issue(1)：76-79,4.DOI:10.3969/j.issn.1002-3429.2017.01.026
CYP2 C19慢代谢患者应用伏立康唑致皮疹及黄视一例分析
One CYP2C19 Poor Metabolizers Patient with Rash and Xanthopsia Induced by Voriconazole:a Case Report
连玉菲 1刘洪涛 1曹格溪 1高海祥 2韩晓雯2
作者信息
- 1. 050051 石家庄，河北省人民医院药学部
- 2. 050051 石家庄，河北省人民医院呼吸科
- 折叠
摘要
Abstract
Objective To investigate the correlation between CYP2C19 genetic polymorphism and adverse drug reac-tion induced by Voriconazole in order to provide references for rational drug use. Methods Clinical data of CYP2C19 poor metabolizers and pulmonary aspergillosis one patient with rash and xanthopsia induced by Voriconazole was retrospectively ana-lyzed. Results The patient was admitted for acute episode of chronic obstructive pulmonary disease. Pulmonary aspergillosis was found by sputum culture,and pulmonary aspergillosis was diagnosed,so the patient was treated with Voriconazole (200 mg,ivgtt,2 times/d,and double dose for first time). Infection symptom was relieved apparently,but a series of symp-toms such as skin rash in both lower extremities,cloudy vision and xanthopsia were found after 3 days of medication. Clinical pharmacists highly suspected that the patient had drug eruptions induced by Voriconazole after excluding organic disease of skin and eyes,and therefore Voriconazole was stopped,and genotype of CYP2C19 was tested for the patient. Xanthopsia was disappeared,and skin rash was relieved on the next day after stopping medication. Gene test showed that CYP2C19*2*3 homozygote mutation( poor metabolizer),so Voriconazole dose was adjusted to 100 mg( ivgtt,2 times/d)subsequently. Pa-tient was discharged after condition improvement by 3 weeks of therapeutics. Conclusion CYP2C19 gene polymorphism is one of important reasons of adverse reactions occurrence induced by Voriconazole,and therefore it can be used to detect Vori-conazole adverse reactions,make individualized treatment plan and provide an objective basis for rational drug use in clinic.关键词
伏立康唑/基因型/药物毒性/疹/黄视/基因检测Key words
Voriconazole/Genotype/Drug toxicity/Exanthema/Xanthopsia/Genetic testing分类
医药卫生引用本文复制引用
连玉菲,刘洪涛,曹格溪,高海祥,韩晓雯..CYP2 C19慢代谢患者应用伏立康唑致皮疹及黄视一例分析[J].临床误诊误治,2017,30(1):76-79,4.
